SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VISTA PHARMACEUTICALS

BSE: 524711 29 Jun 2025
Healthcare
₹ 10.11
Vista Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

VISTA PHARMACEUTICALS - Share Price & Details

Market Cap
₹70.4
High /Low
16.6 / 9.1
Stock P/E
NA
Book Value
₹12.3
Dividend Yield
0.0
ROCE
-8.55
ROE
₹-10.8
Face Value
2.0
PEG Ratio
NA
EVEBITDA
₹-21.5
Debt
7.40
CMP / FCF
-13.1
Debt to equity
₹0.16
NP Ann
-4.65
High price all time
56.2
Piotroski score
₹3.0
Graham Number
NA
No. Eq. Shares
6.16
Net CF
₹0.64
Net profit
-4.65
Price to book value
0.93
Interest Coverage
₹-4.51
Low price all time
0.41
Industry PE
33.8
Reserves
₹33.1
Free Cash Flow
₹-7.42

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
VISTA PHARMACEUTICALS LTD.NANANANA70.4
GODAVARI DRUGS LTD.NANANANA7016.0
VIVO BIO TECH LTD.NANANANA67.99.33

Peer Comparison Chart


About VISTA PHARMACEUTICALS

Vista Pharmaceuticals Ltd., with Security Code 524711, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Breakthrough HAE Treatment Data: Sebetralstat Delivers 1.3-Hour Symptom Relief, Even During Long-term Prophylaxis

(17 Jun 2025)
Latest clinical trial reveals Sebetralstat's 6-minute treatment time for HAE attacks. New data shows effectiveness across multiple...
Read more →

FDA Delays KalVista's Oral HAE Drug Review by 4 Weeks: No Safety Concerns Cited

(14 Jun 2025)
FDA states heavy workload and limited resources prevent meeting PDUFA goal date of June 17. Agency indicates anticipated decision within...
Read more →

KalVista Reveals 6 Major Sebetralstat Studies: New HAE Treatment Data Coming at EAACI 2025

(05 Jun 2025)
... & SALISBURY, England --(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six scientific...
Read more →

KalVista Pharmaceuticals Readies Major Company Updates for Jefferies Healthcare Conference Presentation

(30 May 2025)
... & SALISBURY, England --(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will...
Read more →

KalVista Pharmaceuticals to Present New Sebetralstat Data With 10 Abstracts Accepted at Upcoming Medical Meetings

(22 May 2025)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that it will present...
Read more →

KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference

(01 May 2025)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the Company will...
Read more →